AuPS Logo Programme
Contents
Previous Next PDF

Rat skeletal muscle 3-O-MFPase activity is not decreased by fatiguing in vitro electrical stimulation

C.A. Goodman,1,3 A. Hayes2,3 and M.J. McKenna,1,3 1School of Human Movement, Recreation and Performance, Victoria University, Melbourne, VIC 8001, Australia, 2School of Biomedical and Health Sciences, Victoria University, Melbourne, VIC 8001, Australia and 3Centre for Ageing, Rehabilitation, Exercise and Sport, Victoria University, Melbourne, VIC 8001, Australia.

Maximal 3-O-MFPase activity is a surrogate measure of the Na+,K+-ATPase activity and is commonly utilized in human exercise studies involving skeletal muscle biopsy samples. Studies to date (e.g. Fowles et al., 2002; Petersen et al., 2005), using a range of exercise intensities and durations, have shown that an acute bout of fatiguing exercise results in a decrease in maximal 3-O-MFPase activity at the point fatigue of between ∼11 to 38%. These observations have been interpreted as evidence that the maximal activity of the Na+,K+-ATPase has declined thus contributing to skeletal muscle fatigue. It is speculated that endogenous factors such as reactive oxygen species (ROS) and calcium (Ca2+) may be responsible for this observed reduction in 3-O-MFPase at fatigue. The aim of this study was to investigate whether rat skeletal muscle 3-O-MFPase activity could be reduced further than the above range from human studies by using large isolated skeletal muscles subjected to intense fatiguing in vitro electrical stimulation.

Sprague Dawley (260 ± 9g; Mean ± SE) fast twitch extensor digitorum longus (EDL) muscles (132 ± 4 mg) were dissected out under anaesthesia (Nembutal; ∼85mg/kg) in accordance with Victoria University AEEC procedures and subjected to one of two different stimulation protocols: 1) two bouts of 10s continuous stimulation at a frequency of 100Hz (0.2ms pulse duration) separated by a 1hr recovery period; 2) two bouts of three min intermittent stimulation (1s stimulation at 100Hz followed by 4s recovery) separated by a 1hr recovery period. Tetanic force (500ms, 100Hz, 0.2ms pulse duration) was monitored during recovery. Fatigued muscles and their non-fatigued contra-lateral controls were blotted, weighed, frozen in liquid N2 and maximal 3-O-MFPase activity analysed (Fraser & McKenna, 1998).

At the end of the first bout of 10s continuous stimulation tetanic force had declined by 51.8 ± 1.8% (n = 8) of initial force. Characteristic of high frequency fatigue, force had recovered to 81.2 ± 2.1% of initial after one min and remained relatively constant over the next hour (87.4 ± 2.6% of initial force at one hour). The second stimulation bout reduced force by 50.3 ± 1.3% of initial force, while 3-O-MFPase activity showed no decline (100.5 ± 3.4%; p = 0.9) compared to the non-fatigued, contra-lateral controls. Three minutes of high frequency intermittent stimulation resulted in tetanic force declining by 87.0 ± 1.0% (n = 8) of initial force. After one hour of recovery, tetanic force had gradually recovered to 62.7 ± 2.1% of initial force. At this time, force-frequency analysis showed the presence of low frequency fatigue with relative force being significantly lower at 10 (39.0 ± 2.1% vs 47.0 ± 1.2%; p = 0.005), 30 (44.4 ± 1.4% vs 60.7 ± 1.3%; p < 0.0001) and 50Hz (76.2 ± 1.4% vs 86.7 ± 0.7%; p < 0.0001) compared to pre-fatigue force. The second intermittent stimulation bout reduced force by 83.3 ± 1.3% of initial force while 3-O-MFPase activity was not significantly altered (94.4 ± 3.7%; p = 0.2) when compared to the non-fatigued contra-lateral controls.

In conclusion, under these conditions, rat EDL 3-O-MFPase activity was not reduced by either of the two fatiguing in vitro electrical stimulation protocols. Thus the decline in muscle force was not related to a depression in maximal 3-O-MFPase activity. Whether this reflects a species difference with resistance to Na+,K+-ATPase inactivation in the rat is unclear.

Fowles JR, Green HJ, Tupling R, O'Brien S & Roy BD. (2002) Journal of Applied Physiology, 92: 1585-93.

Fraser SF & McKenna MJ. (1998) Analytical Biochemistry 258:63-7. (2006) Journal of Physiology, 576: 279-88.

Petersen AC, Murphy KT, Snow RJ, Leppik JA, Aughey RJ, Garnham AP, Cameron-Smith D & McKenna MJ. (2005) American Journal of Physiology, 289: R266-74.